Compare Dolby Laboratories, Inc. (DLB) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Kimberly Clark Corp — how do they compare? Dolby Laboratories, Inc. trades at $58.47 (market cap $5.47B), while Kimberly Clark Corp trades at $97.57 (market cap $32.09B). The key difference: Kimberly Clark Corp is far larger — about 5.9× Dolby Laboratories, Inc.'s market cap, and Kimberly Clark Corp pays the higher dividend (5.31%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Kimberly Clark Corp for 93 Days on average.
| DLB | KMB | |
|---|---|---|
Market Cap | $5.47B | $32.09B |
Volume | 691,016 | 2,800,459 |
Sector | Technology | Consumer Staples |
52-Week High | $70.09 | $121.44 |
52-Week Low | $48.51 | $93.05 |
Typical Hold Time | 98 Days | 93 Days |
Enterprise Value | $4.84B | $37.65B |
Dividend Yield | 2.47% | 5.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.
DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.
Kimberly-Clark (KMB) trades at $97.74, up 1.0% on the day, with a bearish technical signal but strong dividend yield of 5.16%. Recent earnings show a mix of beats and a Q2 2026 miss, while the pending Kenvue acquisition and executive transitions dominate news. The stock is undervalued relative to its consensus price target of $117.25, with a P/E of 19.07 and robust profitability metrics including a net income margin of 11.79%.
KMB offers a high dividend yield and valuation upside, but risks include integration challenges from the Kenvue deal, cash flow pressures, and bearish technical trends. Analyst consensus is cautious with 61% hold ratings, reflecting concerns over execution and sustainability of the dividend amid acquisition-related liabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
